Valproic acid Completed Phase 1 Trials for Leukemia Acute Myeloid Leukemia (AML) / Myelodysplastic Syndrome Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT01575691Phase I 5-Azacytidine Plus VPA Plus ATRA